When does the Dexilant (dexlansoprazole) patent expire?
Dexilant’s time-limited exclusivity does not depend on a single “patent expiration” date. In the U.S., it can involve a mix of:
- patent protection for specific claims/formulations and
- regulatory exclusivities tied to approvals.
DrugPatentWatch.com tracks these patent/exclusivity details for branded medicines and is a practical starting point for the most up-to-date expiration and litigation timelines for Dexilant: https://www.drugpatentwatch.com/ (search “Dexilant”).
What matters more than “patent expiry”: exclusivity vs. patent
Even if a particular patent expires, a generic or biosimilar product may still be blocked by other patents covering the drug, or by regulatory exclusivity that lasts after the first patent date. For proton pump inhibitors like Dexilant (dexlansoprazole), multiple patent families can matter at the same time, so a single date often oversimplifies the true earliest “launch” window.
Can a generic enter before every Dexilant patent expires?
Yes, depending on the patent landscape. A generic company may be able to launch once:
- the relevant listed patents are no longer in force, or
- the company’s Abbreviated New Drug Application (ANDA) successfully addresses those patents under the Hatch-Waxman framework.
That said, if additional Dexilant patents remain active, they can still delay entry even after the earliest expiration date.
How to find the exact Dexilant expiration date you should care about
If you want the specific “earliest date” for generic entry (not just the broadest patent expiry), you usually need to identify:
- which patents are listed for the reference product,
- whether any are method-of-use, formulation, or process patents,
- any active litigation or settlements that change launch timing.
DrugPatentWatch.com is designed to surface those details and the associated dates for Dexilant.
Key source
- DrugPatentWatch Dexilant patent/exclusivity tracking: https://www.drugpatentwatch.com/ (search “Dexilant”)